SLC6A12 Knockout HuH-7 Cell Line

The choice depends on whether you are studying SLC6A12 (BGT-1)'s role in betaine/GABA transport or its emerging functions in osmotic regulation and hepatic biology. The Knockout line is appropriate for asking whether BGT-1 is required for betaine uptake — particularly relevant in hepatocyte-derived contexts where betaine is critical for methylation reactions and osmotic protection. Overexpression is useful for transport kinetics studies and for assessing BGT-1 in hyperosmolar adaptation. For betaine/GABA transport research, the EDITGENE SLC6A12 Knockout in Huh-7 is particularly relevant for hepatic methionine cycle and one-carbon metabolism studies — betaine is a major methyl donor in liver. Rescue with wild-type or transport-deficient BGT-1 enables structure-function studies, and is a specificity control for BGT-1 inhibitors (some anticonvulsants like EF1502).

Primary applications: • Betaine uptake assays: ³H-betaine or LC-MS-based intracellular betaine measurement to quantify BGT-1 activity. • GABA transport: ³H-GABA uptake assays to assess BGT-1-dependent GABA transport. • Hepatic one-carbon metabolism: SAM/SAH ratio, methionine cycle metabolite analysis given betaine's role as a major hepatic methyl donor. • Anticonvulsant specificity: BGT-1 inhibitors (e.g., EF1502) specificity testing with the knockout as critical negative control. EDITGENE recommends this model for researchers investigating betaine biology, hepatic methionine cycle, and BGT-1 pharmacology.

Yes. BGT-1 rescue experiments require attention to substrate specificity: • Construct design: use a codon-modified SLC6A12 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane SLC6 architecture must be preserved. • Transport-deficient rescue: substrate-binding mutations enable distinguishing betaine from GABA transport activities. • Functional readout: rescue should restore ³H-betaine and ³H-GABA uptake activities; hepatic methionine cycle metabolite analysis assesses downstream metabolic consequences. • BGT-1 inhibitor selectivity: rescue with wild-type BGT-1 enables specificity testing of anticonvulsants targeting this transporter. Huh-7 transduces efficiently with lentivirus and supports hepatocyte-relevant rescue line studies.